Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,760.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Interim Management Statement

13 Apr 2010 07:00

RNS Number : 0505K
4imprint Group PLC
13 April 2010
 

4imprint Group plc

Interim Management Statement

 

 

The Board of 4imprint Group plc issues its interim management statement for the period 3 January 2010 to 3 April 2010. Seasonally, the first quarter is the least strong of any quarter of the year.

 

The Group delivered a strong sales performance at £40.96m, 15% ahead of Q1 2009 (at constant currency sales were 20% ahead). Sales in all three Divisions increased over prior year. 

 

The North American Direct Marketing business (which represented 60% of Group sales), showed very strong organic growth with Q1 US dollar sales 24% ahead of Q1 2009 and 20% ahead of Q1 2008. Sterling sales in the UK Direct Marketing business were 19% ahead of Q1 2009.

 

The End User Division (Brand Addition) Q1 sales were 18% ahead of Q1 2009, this performance was achieved by securing new contracts in the later part of 2009.

 

In the Trade Division Q1 sales, including inter divisional sales, were 9% ahead of Q1 2009. The Division improved its productivity through a further 9% reduction in total headcount announced in March.

 

 

For further information please contact:

 

Ken Minton

Executive Chairman

4imprint Group plc +44 207 299 7201

 

Gillian Davies

Group Finance Director

4imprint Group plc +44 207 299 7201

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBSGDSCBBBGGD
Date   Source Headline
7th Aug 20247:00 amRNSHalf-year Report
17th Jun 202411:51 amRNSHolding(s) in Company
29th May 20249:27 amRNSEBT Purchase
22nd May 20243:25 pmRNSResult of AGM
22nd May 20247:00 amRNSCFO Succession
22nd May 20247:00 amRNSAGM Statement
16th May 20249:25 amRNSHolding(s) in Company
2nd May 20249:19 amRNSHolding(s) in Company
16th Apr 202410:23 amRNSAnnual Financial Report
3rd Apr 20243:42 pmRNSDirector/PDMR Shareholding
28th Mar 20241:58 pmRNSDirector/PDMR Shareholding
28th Mar 20249:05 amRNSEBT Purchase
13th Mar 20247:00 amRNSFinal Results
28th Feb 20248:33 amRNSHolding(s) in Company
13th Feb 20244:49 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSTrading Statement
8th Jan 20248:27 amRNSBlock listing Interim Review
13th Dec 20238:52 amRNSCommittee changes
4th Dec 20231:23 pmRNSHolding(s) in Company
14th Nov 202312:28 pmRNSEBT Purchase
7th Nov 20237:00 amRNSTrading Statement
9th Oct 20238:17 amRNSEBT Purchase
21st Sep 20238:15 amRNSHolding(s) in Company
18th Aug 20238:09 amRNSDirectorate Change
1st Aug 20238:47 amRNSTrading Statement
31st Jul 20239:20 amRNSTotal Voting Rights
26th Jul 20233:23 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSPension Buy-in Transaction
29th Jun 20239:06 amRNSAdditional Listing
27th Jun 20239:41 amRNSBlock listing Interim Review
6th Jun 20231:36 pmRNSEBT Purchase
24th May 20232:12 pmRNSResult of AGM
24th May 20237:00 amRNSAGM Statement
12th May 20234:01 pmRNSHolding(s) in Company
17th Apr 20235:30 pmRNSAnnual Financial Report
14th Apr 20232:53 pmRNSHolding(s) in Company
29th Mar 20238:38 amRNSDirector/PDMR Shareholding
28th Mar 20238:04 amRNSEBT Purchase
15th Mar 20237:00 amRNSFinal Results
20th Jan 20237:00 amRNSTrading Statement
7th Dec 20223:38 pmRNSEBT Purchase
4th Nov 20227:00 amRNSTrading Statement
27th Oct 202212:42 pmRNSDirector Declaration
10th Oct 20229:01 amRNSEBT Purchase
16th Sep 20221:49 pmRNSHolding(s) in Company
12th Sep 20229:21 amRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report
2nd Aug 20229:13 amRNSHolding(s) in Company
1st Aug 20228:39 amRNSHolding(s) in Company
1st Aug 20228:00 amEQSBloc Ventures: Demand for deep tech unhindered by downturn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.